A fructan from Anemarrhena asphodeloides Bunge showing neuroprotective and immunoregulatory effects

Shaojie Zhang,Qi Zhang,Lijun An,Jiaojiao Zhang,Zhengguo Li,Jie Zhang,Yuhao Li,Muhetaer Tuerhong,Yasushi Ohizumi,Jin Jin,Jing Xu,Yuanqiang Guo

DOI: https://doi.org/10.1016/j.carbpol.2019.115477

2020-02-01

Abstract:A novel polysaccharide, AAP70-1, was isolated from Anemarrhena asphodeloides for the first time. The primary structural analysis revealed that AAP70-1 was composed of glucose and fructose, had an absolute molecular weight of 2720 Da, and contained a (2→6)-linked β-D-fructofuranose (Fruf) backbone and a (2→1,6)-linked β-D-Fruf side chain with an internal α-D-glucopyranose (Glcp) in the form of a neokestose. To explore the potential factors responsible for the medicinally relevant bioactivities of A. asphodeloides, a biological assay was performed. Using flow cytometry analysis, AAP70-1 was experimentally shown to have neuroprotective effects, and it can prevent and ameliorate neurological damage via reducing apoptosis. The immunomodulation assay further revealed that AAP70-1 can significantly improve immune function by promoting phagocytic capacity and the secretion of cytokines (IL-6, IL-1β and TNF-α) in RAW264.7 cells. These results suggest that AAP70-1 has potential as a therapeutic agent for central nervous system diseases or as an immunomodulatory agent.